Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
29385 | 153 | 29.7 | 67% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1609 | 6531 | FCRN//NEONATAL FC RECEPTOR//FC GAMMA RECEPTORS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ASYMMETRIC ANTIBODIES | Author keyword | 17 | 79% | 7% | 11 |
2 | CA215 | Author keyword | 17 | 100% | 5% | 8 |
3 | CARBOHYDRATE ASSOCIATED EPITOPE | Author keyword | 11 | 100% | 4% | 6 |
4 | UBC REPROD HLTH | Address | 9 | 83% | 3% | 5 |
5 | RP215 MONOCLONAL ANTIBODY | Author keyword | 8 | 100% | 3% | 5 |
6 | ASYMMETRIC IGG | Author keyword | 6 | 80% | 3% | 4 |
7 | IMMUNOGLOBULIN SUPERFAMILY PROTEINS | Author keyword | 6 | 80% | 3% | 4 |
8 | RP215 | Author keyword | 6 | 100% | 3% | 4 |
9 | PLACENTAL FACTORS | Author keyword | 3 | 50% | 3% | 5 |
10 | PAN CANCER MARKER | Author keyword | 3 | 100% | 2% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ASYMMETRIC ANTIBODIES | 17 | 79% | 7% | 11 | Search ASYMMETRIC+ANTIBODIES | Search ASYMMETRIC+ANTIBODIES |
2 | CA215 | 17 | 100% | 5% | 8 | Search CA215 | Search CA215 |
3 | CARBOHYDRATE ASSOCIATED EPITOPE | 11 | 100% | 4% | 6 | Search CARBOHYDRATE+ASSOCIATED+EPITOPE | Search CARBOHYDRATE+ASSOCIATED+EPITOPE |
4 | RP215 MONOCLONAL ANTIBODY | 8 | 100% | 3% | 5 | Search RP215+MONOCLONAL+ANTIBODY | Search RP215+MONOCLONAL+ANTIBODY |
5 | ASYMMETRIC IGG | 6 | 80% | 3% | 4 | Search ASYMMETRIC+IGG | Search ASYMMETRIC+IGG |
6 | IMMUNOGLOBULIN SUPERFAMILY PROTEINS | 6 | 80% | 3% | 4 | Search IMMUNOGLOBULIN+SUPERFAMILY+PROTEINS | Search IMMUNOGLOBULIN+SUPERFAMILY+PROTEINS |
7 | RP215 | 6 | 100% | 3% | 4 | Search RP215 | Search RP215 |
8 | PLACENTAL FACTORS | 3 | 50% | 3% | 5 | Search PLACENTAL+FACTORS | Search PLACENTAL+FACTORS |
9 | PAN CANCER MARKER | 3 | 100% | 2% | 3 | Search PAN+CANCER+MARKER | Search PAN+CANCER+MARKER |
10 | ASYMMETRIC IGG ANTIBODIES | 1 | 100% | 1% | 2 | Search ASYMMETRIC+IGG+ANTIBODIES | Search ASYMMETRIC+IGG+ANTIBODIES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CELLULAR CLONE | 27 | 92% | 7% | 11 |
2 | NON AGGLUTINATING ANTIBODIES | 17 | 100% | 5% | 8 |
3 | NON PRECIPITATING ANTIBODY | 12 | 75% | 6% | 9 |
4 | ALPHA HEAVY CHAIN | 7 | 53% | 7% | 10 |
5 | NONPRECIPITATING ASYMMETRIC ANTIBODIES | 6 | 71% | 3% | 5 |
6 | EPITHELIAL CANCER CELLS | 5 | 40% | 7% | 10 |
7 | KAPPA LIGHT CHAIN | 4 | 27% | 8% | 12 |
8 | ASYMMETRIC ANTIBODIES | 4 | 46% | 4% | 6 |
9 | IMMUNOGLOBULIN G EXPRESSION | 3 | 100% | 2% | 3 |
10 | MATING COMBINATION | 2 | 67% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Paradoxical behavior of asymmetric IgG antibodies | 1998 | 43 | 45 | 53% |
Immunoglobulin Expression and Its Biological Significance in Cancer Cells | 2008 | 8 | 43 | 35% |
NONPRECIPITATING ASYMMETRIC ANTIBODIES | 1988 | 43 | 18 | 83% |
The Role of B Cells in Pregnancy: the Good and the Bad | 2013 | 4 | 31 | 16% |
Immunoglobulin Expression in Non-Lymphoid Lineage and Neoplastic Cells | 2009 | 17 | 92 | 15% |
NEED FOR IMMUNOLOGICAL STIMULATORS DURING IMMUNOSUPPRESSION PRODUCED BY MAJOR CANCER-SURGERY | 1985 | 43 | 43 | 2% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UBC REPROD HLTH | 9 | 83% | 3.3% | 5 |
2 | PROV INFECT DIS IMMUNOPATHOL | 3 | 100% | 2.0% | 3 |
3 | ESTUDIOS IMMUNIDAD HUMORAL | 1 | 40% | 1.3% | 2 |
4 | CLIN GENE DIAG THER Y | 1 | 16% | 2.6% | 4 |
5 | AFFILIATED TEACHING HOSP 2 | 1 | 50% | 0.7% | 1 |
6 | CATEDRA IMMUNOL ESTUDIOS INMUNIDAD HUMORAL | 1 | 50% | 0.7% | 1 |
7 | CLIN GYNAECOL 3 | 1 | 50% | 0.7% | 1 |
8 | ESTUDIOS IMMUNIDAD HUMORAL PROF RICARDO A MA | 1 | 50% | 0.7% | 1 |
9 | ESTUDIOS INMUNIDAD HUMORAL DR RICARDO MARGNI | 1 | 50% | 0.7% | 1 |
10 | GYNECOL OBSTETRICIAN | 1 | 50% | 0.7% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000122390 | AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY AND MICROBIOLOGY//JOURNAL OF REPRODUCTIVE IMMUNOLOGY//RECURRENT SPONTANEOUS ABORTION |
2 | 0.0000106874 | AGALACTOSYL IGG//PROT ANALYT CHEM//IGG GLYCOSYLATION |
3 | 0.0000090499 | AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY//DECIDUA//PROGESTERONE INDUCED BLOCKING FACTOR |
4 | 0.0000088287 | ALKALINE PHOSPHATE ACTIVITY//IN VIVO SENSITIZATION//SYNTHETIC LIPID |
5 | 0.0000073394 | BIOL CELLULAIRE EXPT//ADHERING CELLS//EP 89 |
6 | 0.0000067533 | MULTIVALENT IMMUNOTOXINS//KINETIC PARAMETERS OF BINDING//CHRONIC LYMPHOLEUKEMIA |
7 | 0.0000066209 | ROS DNA//ROS HSA//JN MED |
8 | 0.0000063615 | LIPOSOMAL VALINOMYCIN//AGR LIFE SCI BACTERIOL//TETANUS TOXOID ANTIGEN |
9 | 0.0000062940 | FCRN//NEONATAL FC RECEPTOR//TARGET MEDIATED DRUG DISPOSITION |
10 | 0.0000062305 | MU HEAVY CHAIN DISEASE//HEAVY CHAIN DISEASE//GAMMA HEAVY CHAIN DISEASE |